	US 11,654,178 B2
	Cyclic prosaposin peptides and uses thereof
Randolph S. Watnick, Newton, MA (US)
Assigned to CHILDREN'S MEDICAL CENTER CORPORATION, Boston, MA (US)
Filed by CHILDREN'S MEDICAL CENTER CORPORATION, Boston, MA (US)
Filed on Nov. 3, 2021, as Appl. No. 17/518,074.
Application 17/518,074 is a division of application No. 16/854,792, filed on Apr. 21, 2020, granted, now 11,191,805.
Application 16/854,792 is a division of application No. 15/128,617, granted, now 10,646,541, issued on May 12, 2020, previously published as PCT/US2015/022745, filed on Mar. 26, 2015.
Claims priority of provisional application 61/970,853, filed on Mar. 26, 2014.
Prior Publication US 2022/0152146 A1, May 19, 2022
Int. Cl. A61K 38/12 (2006.01); C07K 7/64 (2006.01); A61K 38/08 (2019.01)

CPC A61K 38/12 (2013.01) [A61K 38/08 (2013.01); C07K 7/64 (2013.01)]

5 Claims

1. A method for reducing inflammation in a subject in need thereof, the method comprising: administering to the subject an effective amount of a cyclic peptide, wherein the amino acid sequence of the cyclic peptide is selected from the group consisting of DWGPK (SEQ ID NO: 2) and dWGPK (SEQ ID NO: 4).